Nanovibronix Profit Margin 2014-2019 | NAOV
Current and historical gross margin, operating margin and net profit margin for Nanovibronix (NAOV) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Nanovibronix net profit margin as of September 30, 2019 is -1166.6%.
|Nanovibronix Annual Profit Margins
|Nanovibronix Quarterly Profit Margins
||Medical Instruments Manufacturing
NanoVibronix, Inc. is a medical device company. The Company's products include WoundShield(TM), a patch-based therapeutic ultrasound device which facilitates tissue regeneration and wound healing; PainShield(R), a disposable patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures; UroShield(TM), an ultrasound-based product which is designed to prevent biofilm in urinary catheters; NanoVibronix, lightweight pump which allow contamination-free handling of infected wound exudate and enhanced patient mobility. NanoVibronix, Inc. is based in Melville, New York.